NCT07471841 2026-03-13Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received VenetoclaxHoosier Cancer Research NetworkPhase 2 Not yet recruiting25 enrolled
NCT07411586 2026-02-17Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid LeukemiaM.D. Anderson Cancer CenterPhase 1 Not yet recruiting20 enrolled